Vanda Pharmaceuticals Inc. (VNDA) SEC Filings — 2024

Filings

• Vanda Pharmaceuticals Files Q3 2024 10-Q — 10-Q · Nov 7, 2024
• Vanda Pharmaceuticals Files 8-K — 8-K · Nov 6, 2024
• Vanda Pharmaceuticals Files 8-K — 8-K · Oct 15, 2024
• Vanda Pharmaceuticals Files 8-K — 8-K · Oct 3, 2024
• Vanda Pharmaceuticals Files 8-K — 8-K · Sep 19, 2024
• Vanda Pharmaceuticals Files 8-K: Material Definitive Agreement — 8-K · Aug 8, 2024
• Vanda Pharmaceuticals Files Q2 2024 10-Q — 10-Q · Aug 1, 2024
• Vanda Pharmaceuticals Files 8-K on Financials — 8-K · Jul 31, 2024
• Vanda Pharmaceuticals to be Acquired by Future Pak for $465M — 8-K · Jun 20, 2024
• Vanda Pharmaceuticals Files 8-K Report — 8-K · Jun 13, 2024
• Vanda Pharmaceuticals Files 8-K — 8-K · Jun 6, 2024
• Vanda Pharmaceuticals Files 8-K — 8-K · May 24, 2024
• Vanda Pharmaceuticals Files 8-K on Shareholder Vote Matters — 8-K · May 20, 2024
• Vanda Pharma Files Definitive Additional Proxy Materials — DEFA14A · May 13, 2024
• Vanda Pharma Mails Stockholder Letter — DEFA14A · May 9, 2024
• Vanda Pharmaceuticals Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
• Vanda Pharmaceuticals Files 8-K on Financials — 8-K · May 8, 2024
• Vanda Pharmaceuticals Files 8-K — 8-K · May 7, 2024
• Vanda Pharmaceuticals Files 8-K: Material Agreement Details — 8-K · May 3, 2024
• Vanda Pharmaceuticals Inc. Announces Annual Meeting of Stockholders on May 17, 2024 — DEF 14A · Apr 29, 2024
• Vanda Pharmaceuticals Files 8-K: Material Agreement Details — 8-K · Apr 17, 2024
• Vanda Pharmaceuticals Files 8-K — 8-K · Apr 3, 2024
• Vanda Pharmaceuticals to be Acquired for $465M — 8-K · Mar 7, 2024
• Vanda Pharma Files 8-K on Officer/Director Changes & Compensation — 8-K · Feb 21, 2024
• Vanda Pharma Amends 8-K Filing for Financial Statements and Exhibits — 8-K/A · Feb 16, 2024
• Vanda Pharmaceuticals Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
• Vanda Pharmaceuticals Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
• Dimensional Fund Advisors Amends Vanda Pharma Stake — SC 13G/A · Feb 9, 2024
• Vanda Pharmaceuticals Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 8, 2024
• Vanda Pharma Files 8-K on Operations & Financial Condition — 8-K · Feb 7, 2024
• Vanda Pharma Files 8-K for 'Other Events' on Feb 5, 2024 — 8-K · Feb 5, 2024
• BlackRock Amends Vanda Pharma Stake, Signals Portfolio Shift — SC 13G/A · Jan 23, 2024
• State Street Corp. Updates Passive Stake in Vanda Pharma — SC 13G/A · Jan 22, 2024